P1534: SAFETY AND TOLERABILITY OF NIPOCALIMAB ADMINISTERED AT DIFFERENT RATES OF INTRAVENOUS INFUSION IN HEALTHY ADULTS: A PHASE 1 PLACEBO-CONTROLLED SINGLE-DOSE STUDY

Bibliographic Details
Main Authors:	J. Leu, A. Vermeulen, L. Ling
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000848992.72150.d6

PO.6.134 Safety and tolerability of nipocalimab administered at different rates of intravenous infusion in healthy adults: a phase 1 placebo-controlled single-dose study
by: L Ling, et al.
Published: (2022-10-01)

Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study
by: Jocelyn H. Leu, et al.
Published: (2024-02-01)

P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
by: J. Leu, et al.
Published: (2022-06-01)

Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects
by: Xin Li, et al.
Published: (2023-03-01)

Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects
by: Courtney Tiffany, et al.
Published: (2022-09-01)

Smart Intravenous Infusion Dosing System
by: Dragana Oros, et al.
Published: (2021-01-01)

611 Efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus: design of a phase 2 study
by: Robert W Hoffman, et al.
Published: (2022-12-01)

Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs
by: Seula Lim, et al.
Published: (2019-12-01)

Hemodynamic effects of carbetocin administered as an intravenous bolus or infusion during cesarean delivery
by: Kihyug Kwon, et al.
Published: (2020-04-01)

LP-195 Design of a Phase 2 study evaluating the efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus
by: Robert Hoffman, et al.
Published: (2023-07-01)

Tolerability, safety and efficacy of conventional amphotericin B administered by 24-hour infusion to lung transplant receipients
by: A Dutly, et al.
Published: (2002-08-01)

The Rate of Infusion Represents an Important Aspect of Administering Anticancer Agents
by: Lan MJ, et al.
Published: (2023-11-01)

Pharmacokinetics of a continuous intravenous infusion of hydromorphone in healthy dogs
by: Candace Wimbish, et al.
Published: (2024-04-01)

Safety of rapid intravenous paracetamol infusion in paediatric patients
by: Astrid Eliasen, et al.
Published: (2022-01-01)

Effects of an intravenous infusion of diltiazem on glomerular filtration rate, electrolyte excretion, and urine output in healthy dogs
by: Megan D. Kelley, et al.
Published: (2022-11-01)

Safety, tolerability and pharmacokinetics of single doses of oxytocin administered via an inhaled route in healthy females: randomized, single-blind, phase 1 study
by: Fernando, D, et al.
Published: (2017)

Safety, tolerability and pharmacokinetics of forsythin in healthy subjects: a double-blinded, placebo-controlled single-dose and multiple-dose escalation and food effect study
by: Cuiyun Li, et al.
Published: (2023-12-01)

MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose)
by: Baltazar Gomez‐Mancilla, et al.
Published: (2023-11-01)

The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants
by: Li W, et al.
Published: (2023-11-01)

Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs
by: Laura Cresti, et al.
Published: (2022-11-01)

What happanes when a large dose of magnesium sulphate is infused intravenously?
by: Ali Ghavidel
Published: (2016-05-01)

Evaluation of the safety and tolerability of exogenous ketosis induced by orally administered free beta-hydroxybutyrate in healthy adult subjects
by: Adrian Soto-Mota, et al.

Pharmacokinetics of intravenously and trans-dermally administered fluralaner in healthy laying shaver hens: fluralaner in chickens
by: Baxter A. Elliot, et al.
Published: (2024-03-01)

Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
by: Brian Baker, et al.
Published: (2022-10-01)

Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study
by: Rohit Aggarwal, et al.
Published: (2024-01-01)

LSO-091 Study design of ENERGY: a phase 2/3 trial to assess the efficacy and safety of nipocalimab in warm autoimmune hemolytic anemia
by: Kristen Sweet, et al.
Published: (2023-07-01)

Safety and tolerability of short‐term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open‐label, phase 2/3 trial
by: Mark Kristof Farkas, et al.
Published: (2023-03-01)

High Dose Intravenous Corticosteroid Versus Placebo in Recent Traumatic Optic Neuropathy
by: N Daftarian, et al.
Published: (2009-02-01)

Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies”
Published: (2024-03-01)

Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
by: Thomas Daix, et al.
Published: (2023-03-01)

Maximum tolerated dose and toxicity evaluation of orally administered docetaxel granule in mice
by: Xiaowei Dong, et al.
Published: (2024-06-01)

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
by: Severin B. Vogt, et al.
Published: (2023-05-01)

EFFICACY AND SAFETY OF IBANDRONIC ACID ADMINISTERED INTRAVENOUSLY TO JUVENILE ARTHRITIS PATIENTS WITH SEVERE SYSTEM OSTEOPOROSIS
by: R.V. Denisova, et al.
Published: (2011-01-01)

EFFICACY AND SAFETY OF IBANDRONIC ACID ADMINISTERED INTRAVENOUSLY TO JUVENILE ARTHRITIS PATIENTS WITH SEVERE SYSTEM OSTEOPOROSIS
by: R.V. Denisova, et al.
Published: (2011-11-01)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
by: Xue Zhao, et al.
Published: (2023-08-01)

Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder
by: David Hough, et al.
Published: (2023-11-01)

Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys
by: Jason Pinkstaff, et al.
Published: (2023-01-01)

Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
by: Shanshan Li, et al.
Published: (2023-05-01)

First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study
by: Hongzhong Liu, et al.
Published: (2024-01-01)

Evaluation of postoperative analgesic efficacy and perioperative hemodynamic changes with low dose intravenous dexmedetomidine infusion in patients undergoing laparoscopic cholecystectomy – A randomised, double-blinded, placebo-controlled trial
by: Geetanjali T Chilkoti, et al.
Published: (2020-01-01)

P1534: SAFETY AND TOLERABILITY OF NIPOCALIMAB ADMINISTERED AT DIFFERENT RATES OF INTRAVENOUS INFUSION IN HEALTHY ADULTS: A PHASE 1 PLACEBO-CONTROLLED SINGLE-DOSE STUDY

Similar Items

Similar Items